
AC Immune (ACIU) Stock Forecast & Price Target
AC Immune (ACIU) Analyst Ratings
Bulls say
AC Immune is a promising biopharmaceutical company with a strong focus on Precision Medicine for neurodegenerative diseases. With a diverse pipeline of small molecules, antibodies, and vaccines targeting misfolded proteins, the company is well-positioned for success in this market. The recent positive PD data, potential for plaqu
Bears say
AC Immune is a clinical stage company with a highly focused pipeline on Precision Medicine for neurodegenerative diseases. However, their pipeline is heavily reliant on partnerships and collaborations, and their internal programs face competition from already established players in the market. The upcoming readouts for ACI-24 and BIIB80 will be important to watch for potential positive progress, but overall, the company may struggle to establish a competitive advantage in a highly competitive and challenging market for neurodegenerative disease treatments.
This aggregate rating is based on analysts' research of AC Immune and is not a guaranteed prediction by Public.com or investment advice.
AC Immune (ACIU) Analyst Forecast & Price Prediction
Start investing in AC Immune (ACIU)
Order type
Buy in
Order amount
Est. shares
0 shares